View Information Collection Request (ICR) Package

OMB Control No: 0938-1026	ICR Reference No: 202404-0938-008
Status: Active	Previous ICR Reference No: 202107-0938-005
Agency/Subagency: HHS/CMS	Agency Tracking No: CMCS
Title: [Medicaid] Identifying Medicaid Payment for Physician Administered Drugs (CMS-10215)
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/01/2024
	Date Received in OIRA: 04/12/2024
Terms of Clearance: OMB is approving this information collection request for a period of three years during which time the agency will request approval to extend or revise the collection if the agency seeks to continue the information collection activity beyond the period approved under this action.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2027	36 Months From Approved	08/31/2024
Responses	39,053,932	0	84,589,433
Time Burden (Hours)	162,074	0	351,046
Cost Burden (Dollars)	0	0	0

Abstract: Section 6002 of the Deficit Reduction Act (DRA) of 2005 added provisions under section 1927 of the Social Security Act to require physicians in their offices and hospital outpatient settings or other entities (e.g., non-profit facilities) to collect and submit the drug National Drug Code (NDC) numbers on Medicaid claims to their State in order for Federal Financial Participation to be available for these drugs. We estimate that there are 20,000 physicians in their offices, hospital outpatient settings or other entities (e.g., non-profit facilities) concentrating in the specialties of oncology, rheumatology and urology will be required by their State Medicaid Programs to collect and submit Healthcare Common Procedure Coding System (HCPC) J drug code data match with NDC numbers. CMS released a letter to State Medicaid Directors on July 11, 2006 to explain the requirements of the State collection and submission of the drug NDC numbers on Medicaid claims. This collection is also associated with CMS-2238-FC Medicaid Program: Prescription Drugs published under Volume 72, Number 136, Tuesday, July 17, 2007, Rules and Regulations (RIN 0938-AO20). The requirements for this collection are codified under 42 Code of Federal Regulations section 447.520 Federal Financial Participation: Conditions relating to physician administered drugs.

Authorizing Statute(s): PL: Pub.L. 109 - 171 6002 Name of Law: Deficit Reduction Act of 2005

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 5548	01/29/2024
30-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 24479	04/08/2024
Did the Agency receive public comments on this ICR? No

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Identifying Medicaid Payment for Physician Administered Drugs

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Adjustment in Estimate
Annual Number of Responses	39,053,932	84,589,433	-45,535,501
Annual Time Burden (Hours)	162,074	351,046	-188,972
Annual Cost Burden (Dollars)	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: In this 2024 PRA iteration, we are not proposing changes to any of our requirements. As indicated below in section 15, we are adjusting our total number of responses, time, and cost estimates based on FFY 2022 claims data. Overall, this iteration increases the number of respondents by 6,000, decreases the number of responses by minus 45,535,501, and decreases our active time estimate by minus 188,972 hours. Our time per response is unchanged. Our cost estimate had decreased by minus $7,066,714. See section 15 of this Supporting Statement for details.

Annual Cost to Federal Government: $15,284

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Mitch Bryman 410 786-5258 Mitch.Bryman@cms.hhs.gov

View ICR - OIRA Conclusion